2-PAM Autoinjectors Project Bioshield

SOL #: 75A50126R00002Pre-Solicitation

Overview

Buyer

Health And Human Services
Office Of Assistant Secretary For Preparedness And Response
BARDA - ASPR / DAAPPO / BARDA DCMA
WASHINGTON, DC, 20515, United States

Place of Performance

Washington, DC

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

Community And Regional Development R&D Services; Community Development; Applied Research (AB12)

Set Aside

No set aside specified

Timeline

1
Posted
May 28, 2026
2
Response Deadline
Jun 16, 2026, 9:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Health and Human Services (HHS), specifically BARDA, has issued a Presolicitation for the 2-PAM Autoinjectors Project Bioshield. This initiative seeks late-stage clinical development, regulatory approval, and procurement of 2-PAM autoinjectors. These autoinjectors are a drug/device combination product intended to treat organophosphate (OP) poisoning, including nerve agents, in both adult and pediatric populations. The procurement is for the Strategic National Stockpile (SNS)/CHEMPACK Program. Responses are due June 16, 2026.

Scope of Work

  • Late-stage clinical development of 2-PAM autoinjectors.
  • Regulatory approval for 2-PAM autoinjectors as a drug/device combination product.
  • Treatment focus: Organophosphate (OP) poisoning, including nerve agents, for adult and pediatric populations.
  • Procurement: Supply 2-PAM autoinjectors for the SNS/CHEMPACK Program.

Contract & Timeline

  • Opportunity Type: Presolicitation
  • Set-Aside: None specified
  • Response Due: June 16, 2026 (21:00:00Z)
  • Published Date: May 28, 2026 (20:38:22Z)
  • Department/Office: Health And Human Services / BARDA - ASPR / DAAPPO / BARDA DCMA
  • Place of Performance: Washington, DC, United States

Additional Notes

This notice serves as a presolicitation, indicating an upcoming formal solicitation. Interested parties should monitor SAM.gov for further details and the release of the Request for Proposals (RFP) or similar documents.

People

Points of Contact

Erin Greninger, Contracting OfficerPRIMARY
erin.greninger@hhs.gov
Greg SmithSECONDARY
greg.smith1@hhs.gov

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Pre-Solicitation
Posted: May 28, 2026
2-PAM Autoinjectors Project Bioshield | GovScope